CClinicalTrials.gg
RecruitingNCT05854264MicrobiotaUpdated May 11, 2023

Influence of Nutrition on Lung Microbiota in Traumatic Brain Injury

An interventional study of standard enteral nutrition and specialized nutrition in Microbial Colonization, sponsored by University of Foggia. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-05-11.

Sponsored by University of Foggia · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Role of immunonutrition in modulating the lung microbiota of intubated TBJ patients and how this interaction may affect the infections and outcomes.

For these reasons, the aims of our study are the evaluation of the impact of immunonutrition on the lung microbiota and the relationship between lung microbiota and infection in TBJ patients in ICU.

Read the detailed description

Traumatic brain injury patients, requiring mechanical ventilation admitted to ICU will be randomly divide in two groups receiving standard nutrition or specialized formula.

Lower lavage (Bronco Alveolar Lavage: BAL) samples will be collected at admission in ICU and at day 7 for the microbiota analysis. Clinical follow-up at day 28 will be obtained

02

Conditions studied

03

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • adults (age > 18 years),
  • paziente with traumatic brain injury

Exclusion criteria

Exclusion Criteria:

  • pregnant women,
  • patients with gastric content inhalation
  • patients with chronic inflammatory bowel diseases
  • patients underwent major abdominal surgery and/or organs/tissues transplant
  • patients on corticosteroid and/or immunosuppressive therapy
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    microbiota and specialized nutrition

    microbiota analysis in lower lavage (Bronco Alveolar Lavage: BAL) samples in patietns treated with specialized nutrition

    Dietary Supplement: specialized nutrition

  • Sham comparator
    microbiota and standard nutrition

    microbiota analysis in lower lavage (Bronco Alveolar Lavage: BAL) samples in patients treated with standard nutrition

    Dietary Supplement: standard enteral nutrition

Interventions

  • Dietary supplementstandard enteral nutrition

    standard enteral nutrition. The calories (25 kcal/kg/die) and protein (1.2 g/kg/die) target will be progressively reached in the first week of ICU stay.

  • Dietary supplementspecialized nutrition

    specialized enteral nutrition. The calories (25 kcal/kg/die) and protein (1.2 g/kg/die) target will be progressively reached in the first week of ICU stay.

05

What researchers measure

Primary outcomes

  1. infection

    pulmonary infection in mechanically ventilated patients

    Time frame: pulmonary infection within 28 days

06

Study locations

1 of 1 sites recruiting
07

Registry details

Key details

Study ID
NCT05854264
Lead sponsor
University of Foggia
Responsible party
Cotoia Antonella (Principal Investigator, University of Foggia) — Principal investigator
First posted
May 11, 2023
Start date
Feb 1, 2021
Primary completion
Apr 30, 2023 (estimated)
Completion
May 1, 2023 (estimated)
Last update
May 11, 2023

Study contacts

Antonella Cotoia
Contact
antonella.cotoia@unifg.it
+390881732387

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion